CONF

COM:CONFOTHERAPEUTICS

Confo Therapeutics

  • Privately Held

Confo Therapeutics uses its proprietary technology to stabilize functional conformations of GPCRs (G protein-coupled receptors) to discover drug targets. The self-described leader develops a pipeline of drug candidates to treat severe illnesses lacking disease-modifying treatments. Confo Therapeutics has an international team of scientists and business professionals.

peer of

investor of